00006-5083 KEYTRUDA QLEX

Product NDC:

00006-5083

Brand Name:

KEYTRUDA QLEX

Generic Name:

Pembrolizumab and berahyaluronidase alfa-pmph

Dosage Form Name:

INJECTION, SOLUTION

Administration Route:

Subcutaneous

Substances:

Name: BERAHYALURONIDASE ALFA

Strength: 2000.0

Unit: U/mL

Name: PEMBROLIZUMAB

Strength: 165.0

Unit: mg/mL

Packages:

Code: 00006-5083-01

Description: 1 VIAL in 1 CARTON (0006-5083-01) / 4.8 mL in 1 VIAL (0006-5083-99)

Effective Date: Sept. 19, 2025

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Checkpoint Inhibitor

Minor Class:

PD-1

Orphan Drug Designation:

Status:

In Use

CanMED: NDC